{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/gonorrhoea/how-up-to-date-is-this-topic/changes/","result":{"pageContext":{"chapter":{"id":"41812e79-dbe3-5991-8344-05de91dff192","slug":"changes","fullItemName":"Changes","depth":2,"htmlHeader":"<!-- begin field 26bc71f6-b2ae-4f37-9939-3400916413b1 --><h2>Changes</h2><!-- end field 26bc71f6-b2ae-4f37-9939-3400916413b1 -->","summary":null,"htmlStringContent":"<!-- begin item 73f59c6b-bf0a-459e-9c6e-b53fb09a4ba7 --><!-- begin field 188647ec-8acd-4e8b-b861-610036a02338 --><p><strong>November 2020 </strong>— minor update. Cautions for prescribing quinolones updated in line with revised manufacturer's SPC. </p><p><strong>March 2019 </strong>— minor update. Prescribing information for quinolones updated in line with MHRA, 2019, <em>Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/gonorrhoea/references/\">MHRA, 2019</a>]. </p><p><strong>January 2019</strong> — minor update. Prescribing information updated to be brought in line with updated BASHH guideline <em>UK national guideline for the management of gonorrhoea in adults </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/gonorrhoea/references/\">BASHH, 2019</a>].</p><p><strong>January 2019</strong> — minor update. Aortic aneurysm and dissection are now listed as an adverse effect of ciprofloxacin. </p><p><strong>June 2018 </strong>— minor update. Prescribing information updated with information regarding azithromycin interacting with colchicine.  </p><p><strong>September 2017 </strong>— minor update. SPC update on quinolones to align all CKS topics prescribing advice. Prostatitis – chronic, Gonorrhoea, Pyelonephritis, Diarrhoea – prevention and advice for travellers, Dyspepsia – unidentified cause, Dyspepsia – proven functional, Dyspepsia – proven peptic ulcer, Diverticular disease, Gastroenteritis and Scrotal pain and swellings. </p><p><strong>May to June 2017</strong> — reviewed. A literature search was conducted in May 2017 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of the topic. </p><!-- end field 188647ec-8acd-4e8b-b861-610036a02338 --><!-- end item 73f59c6b-bf0a-459e-9c6e-b53fb09a4ba7 -->","topic":{"id":"8aeba2d1-9f1a-5428-a119-41fa94223706","topicId":"4b4cdbb6-97a0-4b13-a04c-d857b72bcddf","topicName":"Gonorrhoea","slug":"gonorrhoea","lastRevised":"Last revised in November 2020","chapters":[{"id":"803822d1-16b6-5c36-b47d-9a6e8e236c06","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"b8d98590-b989-554f-8ccb-804279dab0d2","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"4ac6e3b9-f31e-5367-b177-171c1cd87bd7","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"41812e79-dbe3-5991-8344-05de91dff192","slug":"changes","fullItemName":"Changes"},{"id":"bbabf43d-27dd-5795-b02b-9891c7e9e7ca","slug":"update","fullItemName":"Update"}]},{"id":"cd231f06-b527-5de3-a8cb-277fd6f84587","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"858e0da7-8025-510b-ac87-1055c9b510e0","slug":"goals","fullItemName":"Goals"},{"id":"b9efda8e-7814-5479-af6b-1272844f3546","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"874bc02c-2022-584f-bc91-b99489f3ac6c","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"17fcc032-43d9-5c38-b19b-e10bef0648f1","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"1033f77b-d5e5-5700-b7f9-f314bb1daef3","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"11e8f7de-1c3f-5692-a9e4-f2c1645e1023","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"f889ee27-2135-5f9e-b131-fb46452febe4","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"55283c6e-a75b-5deb-8827-406245e897ff","slug":"definition","fullItemName":"Definition"},{"id":"cf7e0416-d49c-57de-8063-ebf536922bcc","slug":"prevalence","fullItemName":"Prevalence"},{"id":"6c929d32-5621-5a53-9e9b-63a3e1523e20","slug":"prognosis","fullItemName":"Prognosis"},{"id":"1196a066-1188-5938-b1d3-932dd0ffc403","slug":"complications","fullItemName":"Complications"}]},{"id":"acc7ed62-ebd4-506d-a105-4b05f6f7e38a","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"a9a1ae79-f8a2-59e3-a720-8207d27eee47","slug":"assessment","fullItemName":"Assessment"},{"id":"0ee9cef7-bd86-583b-9d57-f5d8f9a5d6d0","slug":"signs-symptoms-in-a-man","fullItemName":"Signs and symptoms in a man"},{"id":"9b460f20-3213-5956-896f-ccc5156c9d32","slug":"signs-symptoms-in-a-woman","fullItemName":"Signs and symptoms in a woman"},{"id":"e568c796-6f9e-5513-a973-7efca33d5b62","slug":"confirmation-of-diagnosis","fullItemName":"Confirmation of diagnosis"},{"id":"44933641-db44-5935-9459-ea8e78869d57","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"},{"id":"e0f6f6d2-d4a8-5801-b817-0588e8540a04","slug":"possible-sexual-abuse","fullItemName":"Possible sexual abuse"}]},{"id":"d05b0423-47bb-53df-ab5a-8730ca4d3325","fullItemName":"Management","slug":"management","subChapters":[{"id":"171cfead-d784-5eab-b668-c3fe9015a93a","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"98eac615-b29a-5de3-a795-37b42615eb61","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"9c11c59e-3407-52b9-a870-aed88dcd9236","slug":"cephalosporins-ceftriaxone-or-cefixime","fullItemName":"Cephalosporins (ceftriaxone or cefixime)"},{"id":"af56affe-2e43-5ee7-b94a-333ead3b8efa","slug":"quinolones-ciprofloxacin-or-ofloxacin","fullItemName":"Quinolones (ciprofloxacin or ofloxacin)"},{"id":"caa85d19-223f-5ca5-ae12-313a1b2462d1","slug":"azithromycin","fullItemName":"Azithromycin"}]},{"id":"39f7e7ee-870b-55c8-9cd9-55320d487f24","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"05886abb-50fd-51e9-b3c2-e2e99ad9b241","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"bdd6db63-13f7-5183-a3a2-63b619818fb3","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"0d44a69c-3824-5509-a756-cda3bc1bd50a","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"e5526ef2-c93a-595d-a0c1-8068bad91f10","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"0092236d-21ec-5777-85c0-6e95f9962a15","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"8791b380-0e55-5489-987e-5db590030323","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"bc36d12c-c9a8-5970-8b4b-74304413a1f0","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"4ac6e3b9-f31e-5367-b177-171c1cd87bd7","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"b3c6018c-ff0b-5ac4-8d75-42954e6d2432","slug":"previous-changes","fullItemName":"Previous changes","depth":3,"htmlHeader":"<!-- begin field 12b6c936-6052-49ab-9722-f24fb0004774 --><h3>Previous changes</h3><!-- end field 12b6c936-6052-49ab-9722-f24fb0004774 -->","summary":null,"htmlStringContent":"<!-- begin item a6f7f5af-cbe2-4c39-ae16-58d595b40967 --><!-- begin field 8d92b27b-5f50-42c3-abc3-6b727ace660a --><p><strong>December 2016</strong> — minor update. Uveitis, severe liver injury and exfoliative dermatitis have been added as possible adverse effects of ofloxacin, in line with the manufacturer's updated Summary of Product Characteristics.</p><ul><li>Drug reaction with eosinophilia and systemic symptoms (DRESS) has been added as a possible adverse effect of azithromycin.</li><li>Information that the World Health Organization (WHO) guideline <em>Treatment of Neisseria gonorrhoeae,</em> recommends a lower dose of ceftriaxone has been added to this topic.</li></ul><p><strong>September 2014 </strong>— minor update. The Public Health England (PHE) have released updated guidance on the detection of gonorrhoea in England.</p><p><strong>February 2013 </strong>— minor update. The 2013 QIPP options for local implementation have been added to this topic.</p><p><strong>January 2013 </strong>— minor update. Typographical error corrected in the prescribing information section on cephalosporins.</p><p><strong>October 2012 </strong>— minor update. The 2012 QIPP options for local implementation have been added to this topic.</p><p><strong>September 2011 </strong>— updated to reflect the revised UK National Guideline for the Management of Gonorrhoea in Adults 2011, published by the British Association for Sexual Health and HIV (BASHH). Issued in November 2011.</p><p><strong>May 2011 </strong>— minor update. The 2010/2011 QIPP options for local implementation have been added to this topic. Issued in June 2011.</p><p><strong>September 2010 </strong>— minor update. Health Protection Agency (HPA) figures for new diagnoses of gonorrhoea in 2008/9 have been added, and the lower age limit for quinolone prescriptions has been raised from 16 to 18 years. Issued in September 2010.</p><p><strong>October 2009 </strong>— minor update. Minor change to wording of basis regarding amoxicillin use in pregnant and breastfeeding women. Issued in October 2009.</p><p><strong>October 2009 </strong>— minor update. Recommendations from the National Institute for Health and Clinical Excellence (NICE) on when to suspect has been added to the section. Issued in October 2009.</p><p><strong>July to September 2009 </strong>— this is a new CKS topic. The evidence-base has been reviewed in detail, and recommendations are clearly justified and transparently linked to the supporting evidence.</p><!-- end field 8d92b27b-5f50-42c3-abc3-6b727ace660a --><!-- end item a6f7f5af-cbe2-4c39-ae16-58d595b40967 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}